Biallelic inactivating germline mutations in the PALB2 gene lead to Fanconi anemia (Fanconi anemia type N), whereas monoallelic mutations are associated with an increased risk of breast, pancreatic, and possibly ovarian cancer [9–14]. The gene discussed is PALB2; the disease is ovarian cancer.